Kidney biopsy for the diagnosis and treatment of kidney diseases. Recommendations from the French speaking Society of Nephrology (SFNDT) and French National Authority for Health (HAS) 2022

Nephrol Ther. 2024 Feb 28;20(1):61-80. doi: 10.1684/ndt.2024.68. Epub 2024 Feb 21.ABSTRACTKidney Biopsy (KB) is a crucial diagnostic tool in the field of renal diseases and is routinely performed in nephrology departments. A previous survey conducted by the Société Francophone de Néphrologie Dialyse Transplantation (SFNDT) revealed significant disparities in clinical practices, sometimes conflicting with the existing literature and recently published recommendations. In response, the SFNDT wished to promote the development of best practice guidelines, under the auspices of the French National Authority for Health (HAS), to establish a standardized framework for performing kidney biopsies in France.PMID:38379375 | DOI:10.1684/ndt.2024.68

Source: Nephrologie and Therapeutique - February 21, 2024 Category: Urology & Nephrology Authors: Louis de Laforcade Micka ël Bobot Jean-Jacques Boffa Christophe Bovy Claire Cartery Dominique Chauveau Victor Gueutin Corinne Isnard-Bagnis No émie Jourde Chiche Alexandre Karras Aim èle Meftah Clotilde M üller Pierre Si é Thomas Stehl é Laurence Vr Source Type: research